| |
| |
|
| Insider
Information: |
Vagelos P Roy |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
717,380 |
|
|
Indirect Shares
|
1,322,453 |
|
|
| Direct
Value |
$312,768,276 |
|
|
|
Indirect Value
|
$169,901,771 |
|
|
| Total
Shares |
2,039,833 |
|
|
| Total
Value |
$482,670,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2023-04-03 |
312,578 |
2023-04-03 |
154,526 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2009-12-23 |
404,802 |
2009-12-23 |
1,167,927 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
266 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2020-05-21 |
4 |
AS |
$556.79 |
$83,984,786 |
D/D |
(148,811) |
308,532 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2020-05-21 |
4 |
AS |
$577.37 |
$452,178 |
D/D |
(783) |
307,749 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
73,100 |
234,649 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-07-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
341 |
143,559 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-11 |
4 |
AS |
$594.20 |
$20,174,355 |
I/I |
(33,460) |
50,192 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-10-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
349 |
143,210 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-11-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,406 |
3,609 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-11-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,406 |
47,786 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,439 |
237,088 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-01-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
414 |
142,796 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-02-23 |
4 |
OE |
$52.03 |
$13,007,500 |
D/D |
250,000 |
487,088 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-02-23 |
4 |
D |
$458.48 |
$63,269,323 |
D/D |
(137,998) |
349,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-04-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
446 |
142,350 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-05-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,000 |
327,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-06-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
19,000 |
308,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-07-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
373 |
141,977 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,000 |
291,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-18 |
4 |
AS |
$650.04 |
$6,525,752 |
I/I |
(10,039) |
37,747 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-25 |
4 |
OE |
$179.13 |
$13,434,750 |
D/D |
75,000 |
366,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-25 |
4 |
D |
$667.39 |
$32,890,314 |
D/D |
(49,282) |
316,808 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-10-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
347 |
141,630 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,861 |
318,669 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-12-16 |
4 |
D |
$634.70 |
$80,008 |
I/I |
(126) |
2,095 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
338 |
141,292 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-14 |
4 |
OE |
$179.13 |
$13,434,750 |
D/D |
75,000 |
393,669 |
0 |
- |
|
266 Records found
|
|
Page 10 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
